These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31325582)

  • 1. Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice.
    Pereira AF; Pereira LMS; Silva CMP; Freitas Alves BW; Barbosa JS; Pinto FMM; Pereira AC; Silva KO; Pontes RB; Alencar NMN; Lima-Júnior RCP; Vale ML
    Neurosci Lett; 2019 Sep; 709():134378. PubMed ID: 31325582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice.
    Pereira AF; Lino JA; Alves BWF; Lisboa MRP; Pontes RB; Leite CAVG; Nogueira RB; Lima-Júnior RCP; Vale ML
    Braz J Med Biol Res; 2020; 53(11):e10263. PubMed ID: 32965323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid System Attenuates Oxaliplatin-Induced Peripheral Sensory Neuropathy Through the Activation of CB1 Receptors.
    Pereira AF; Lisboa MRP; de Freitas Alves BW; da Silva CMP; Dias DBS; de Menezes KLS; Cesário FRAS; de França JC; de Oliveira AR; Hallak JEC; Zuardi AW; Crippa JA; de Alencar NMN; Lima-Júnior RCP; Vale ML
    Neurotox Res; 2021 Dec; 39(6):1782-1799. PubMed ID: 34792764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.
    Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M
    Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxic effect of oxaliplatin: Comparison with its oxalate-free analogue cis-[PtII(1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)] (LLC-1402) in mice.
    Pereira AF; de Oliveira FFB; de Freitas Alves BW; de Menezes KLS; de Mesquita AKV; Lisboa MRP; de Sousa KKO; Vale ML
    Toxicol Appl Pharmacol; 2018 Feb; 340():77-84. PubMed ID: 29307816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.
    Azevedo MI; Pereira AF; Nogueira RB; Rolim FE; Brito GA; Wong DV; Lima-Júnior RC; de Albuquerque Ribeiro R; Vale ML
    Mol Pain; 2013 Oct; 9():53. PubMed ID: 24152430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy.
    Fujita S; Hirota T; Sakiyama R; Baba M; Ieiri I
    J Neurochem; 2019 Feb; 148(3):373-385. PubMed ID: 30295925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
    Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
    J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Endothelin Receptors in Peripheral Sensory Neuropathy Induced by Oxaliplatin in Mice.
    Pontes RB; Lisboa MRP; Pereira AF; Lino JA; de Oliveira FFB; de Mesquita AKV; de Freitas Alves BW; Lima-Júnior RCP; Vale ML
    Neurotox Res; 2019 Nov; 36(4):688-699. PubMed ID: 31228092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats.
    Ding R; Wang Y; Zhu JP; Lu WG; Wei GL; Gu ZC; An ZT; Huo JG
    J Integr Neurosci; 2020 Dec; 19(4):663-671. PubMed ID: 33378840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Transcriptome of Dorsal Root Ganglia Reveals Distinct Etiologies of Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy in Rats.
    Sun W; Hao Y; Li R; Ho IHT; Wu S; Li N; Ba X; Wang J; Xiong D; Jiang C; Xiao L; Liu X
    Neuroscience; 2023 Apr; 516():1-14. PubMed ID: 36822350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
    Yi Y; Li L; Song F; Li P; Chen M; Ni S; Zhang H; Zhou H; Zeng S; Jiang H
    Toxicology; 2021 Jul; 459():152853. PubMed ID: 34252480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention.
    Álvarez-Tosco K; González-Fernández R; González-Nicolás MÁ; Martín-Ramírez R; Morales M; Gutiérrez R; Díaz-Flores L; Arnau MR; Machín F; Ávila J; Lázaro A; Martín-Vasallo P
    BMC Neurosci; 2024 Sep; 25(1):44. PubMed ID: 39278931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
    Nishida K; Takeuchi K; Hosoda A; Sugano S; Morisaki E; Ohishi A; Nagasawa K
    Life Sci; 2018 Aug; 207():516-524. PubMed ID: 29981320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.
    Calls A; Torres-Espin A; Tormo M; Martínez-Escardó L; Bonet N; Casals F; Navarro X; Yuste VJ; Udina E; Bruna J
    Ann Clin Transl Neurol; 2022 Dec; 9(12):1985-1998. PubMed ID: 36369764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
    Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
    Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin Regulates Chemotherapy Induced Peripheral Neuropathic Pain in the Dorsal Horn and Dorsal Root Ganglion via the Calcineurin/NFAT Pathway.
    Huang W; Huang J; Jiang Y; Huang X; Xing W; He Y; Ouyang H
    Anticancer Agents Med Chem; 2018; 18(8):1197-1207. PubMed ID: 29793414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice.
    Ogihara T; Nakagawa T; Hayashi M; Koyanagi M; Yonezawa A; Omura T; Nakagawa S; Kitada N; Imai S; Matsubara K
    J Pharmacol Sci; 2019 Dec; 141(4):131-138. PubMed ID: 31734027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
    Taguchi K
    Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study.
    El-Fatatry BM; Ibrahim OM; Hussien FZ; Mostafa TM
    Int J Colorectal Dis; 2018 Dec; 33(12):1675-1683. PubMed ID: 29931409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.